London Swiss Medical is a specialist endocrinology, diabetes and metabolism and general medicine, practice, providing compassionate, evidence-based, personalised medical care. We look after private patients at the Guthrie Clinic at King’s College Hospital in south-east London, at 25 Harley Street, and at The Shard Outpatients Centre at London Bridge Hospital, 120 & 32 Old Broad Street in the City, and 40 Bank Street at Canary Wharf in London Docklands.
Dr Philip Kelly
MB BS, MD, FRCP
Dr Kelly graduated in Medicine and Surgery from The London Hospital Medical College. His higher specialist training in Endocrinology and Diabetes in London, based at Bart's and The London Hospitals. He undertook research into the role of IGF-1 on colon cancer development in acromegaly and the use of somatostatin analogues, and was awarded an MD from the University of London.
He has been a consultant at King's College Hospital, in general and acute medicine since 2013, and provides specialist clinical services for hypertension, and as the endocrinologist to boththe Sarcoid and the Orbital teams.
Professor Martin Whyte
PhD FRCP
Professor Whyte qualified in medicine in 1998 from King’s College London, having previously been awarded a Bachelor of Science degree during his studies. He undertook general and specialist training in Diabetes & Endocrinology in London, including King’s College, Guy’s and St.Thomas’ Hospitals. His PhD was awarded in 2010 for the study of insulin action in critical illness. At King's he works within the specialist diabetes team as well as working with colleagues from The Institute of Liver Studies and department of hepatology. He was awarded his academic Chair from University of Surrey in 2026 where he is now Professor of Metabolic Medicine.
He is an expert in managing type 1 diabetes, but has a particular interest in type 2 diabetes, and the conditions that lead to type 2 diabetes, as well as those associated with it such as metabolic dysfunction associated steatotic liver disease (MASLD), obesity and overweight, and early onset, and severe cardiovascular disease and the dyslipidaemia associated with diabetes.